Emergent BioSolutions Inc (EBS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG, MD 20879

Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through their specialty products and contract development and manufacturing services, the company is dedicated to providing solutions that address public health threats. Through social responsibility, Emergent BioSolutions aims to build healthier and safer communities. The company aspires to deliver peace of mind to theis patients and customers so they can focus on what's most important in their lives. In working together, Emergent envisions protecting or enhancing 1 billion lives by 2030.

Data as of 2021-09-19 11:54:36 -0400
Market Cap3.068 Billion Shares Outstanding53.701 Million Avg 30-day Volume395.423 Thousand
P/E Ratio10.25555 Dividend Yield EPS5.48
Price/Sales1.8 Debt to Equity1.89 EBITDA489.3 Million
Price to Book Value1.99 Forward PE0.29 Enterprise Value3.475 Billion
Total Cash447.5 Million Current Debt377.8 Million Gross Profit1.064 Billion
BETA1.24162 52-week High/Low127.2 / 55.07 Next Earnings Date2021-11-04 Price to Cash FLow (P/CF) 171.352
Data provided by IEX Cloud
View SEC Filings from EBS instead.

View recent insider trading info

Funds Holding EBS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EBS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ZOON KATHRYN C

  • Director
14,377 2021-05-25 2

SULLIVAN LOUIS W

  • Director
44,972 2021-05-20 2

JOULWAN GEORGE A

  • Director
31,798 2021-05-20 1

HAUER JEROME M

  • Director
15,215 2021-05-20 1

RICHARD RONALD

  • Director
13,303 2021-05-20 1

HARSANYI ZSOLT

  • Director
29,606 2021-05-20 1

WHITE MARVIN L

  • Director
8,656 2021-05-20 3

LINDAHL RICHARD S EVP, CHIEF FINANCIAL OFFICER

  • Officer
36,919 2021-05-08 3

KRAMER ROBERT PRESIDENT AND CEO

  • Officer
  • Director
163,053 2021-05-08 6

SMITH KAREN L. EVP, CHIEF MEDICAL OFFICER

  • Officer
11,888 2021-05-07 2

KIRK SEAN EVP, MANUFACTURING & TECH OPS

  • Officer
17,776 2021-03-31 2

BAILEY SUE

  • Director
24,427 2021-03-04 1

HAVEY ADAM EVP, BUSINESS OPERATIONS

  • Officer
38,190 2021-03-01 3

EL-HIBRI FUAD CHAIRMAN

  • Officer
  • Director
41,714 2021-02-24 3

SARAN ATUL EVP, CORP DEV, GC & SECRETARY

  • Officer
106,056 2021-02-24 2

STREI KATHERINE EVP, CHIEF HR OFFICER

  • Officer
74,906 2021-02-24 2

EMERGENT BIOSOLUTIONS INC.

  • SEAN KIRK, EVP, MANUFACTURING
13,604 2019-05-23 0

MULLIGAN SEAMUS

  • Director
594,162 2019-03-19 0

ABDUN-NABI DANIEL CEO

  • Officer
  • Director
144,553 2019-03-04 0

NIEDERHUBER JOHN

  • Director
No longer subject to file 2016-05-18 0

LABINGER BARRY EVP, BIOSCIENCES DIV.

  • Officer
25,182 2015-11-13 0

CHATFIELD STEVEN EVP, BIOSCIENCES

  • Officer
28,000 2013-03-14 0

INTERVAC, L.L.C.

  • 10% Owner
4,344,250 2012-09-18 0

ELSEY R DON CHIEF FINANCIAL OFFICER

  • Officer
26,614 2012-03-13 0

KEESE KYLE EVP, BIOSCIENCES DIVISION

  • Officer
18,759 2011-03-15 0

LOCKHART STEPHEN SVP PRODUCT DEVELOPMENT

  • Officer
6,980 2010-11-11 0

BIOPHARM, L.L.C.

  • 10% Owner
No longer subject to file 2010-05-27 0

ESPOSITO DENISE CLO

  • Officer
0 2009-03-10 0

BIOLOGIKA, L.L.C.

  • MEMBER 13(D) GROUP OWNING >10%
1,399,764 2008-06-04 0

ALLBAUGH JOE M

  • Director
0 2008-05-21 0

MICHIGAN BIOLOGIC PRODUCTS, INC.

  • MEMBER 13(D) GROUP OWNING >10%
1,328,018 2008-01-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 22:15:03 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 21:45:03 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 21:15:03 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 20:45:03 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 20:15:03 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 19:45:03 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 19:15:03 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 18:45:03 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 18:15:03 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 17:45:03 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 17:15:03 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 16:45:03 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 16:15:03 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 15:45:03 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 15:15:04 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 14:45:02 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 14:15:02 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 13:45:02 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 13:15:03 UTC -0.18 0.25 2100000
EMERGENT BIOSOLUTIONS INC EBS 2021-09-24 12:45:03 UTC -0.18 0.25 2100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Defensive Long Fund EBS -57.0 shares, $-3298.02 2020-03-31 N-PORT
RUSSELL INVESTMENT CO- U.S. Dynamic Equity Fund EBS -953.0 shares, $-101828.05 2021-01-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund EBS -1406.0 shares, $-130631.46 2021-03-31 N-PORT
AGF Investments Trust- AGFIQ U.S. Market Neutral Anti-Beta Fund EBS -7371.0 shares, $-464299.29 2021-06-30 N-PORT

Elevate your investments